logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10265363 B1

PDFFull Text
Expired
Date of Patent:
Apr. 23, 2019

Filed:

Aug. 02, 2016

Formulations that provide support during vaccinations and adaptive immune system response

Applicants:

Sarah Morgan, Aurora, CO (US);

Karl Holtzer, Pittsburgh, PA (US);

Inventors:

Sarah Morgan, Aurora, CO (US);

Karl Holtzer, Pittsburgh, PA (US);

Assignee:

Other;

Attorneys:

William C. Yarbrough, III

Kearney, McWilliams & Davis, PLLC

Primary Examiner:

Layla Soroush

Int. Cl.
CPC ...
A61K 31/07 (2006.01); A61K 31/14 (2006.01); A61K 31/19 (2006.01); A61K 31/51 (2006.01); A61K 33/06 (2006.01); A61K 33/18 (2006.01); A61K 36/28 (2006.01); A61K 39/00 (2006.01); A61K 31/122 (2006.01); A61K 31/194 (2006.01); A01N 43/00 (2006.01); A01N 43/46 (2006.01); A61K 31/55 (2006.01); A61K 31/197 (2006.01); A61K 31/355 (2006.01); A61K 31/375 (2006.01); A61K 31/455 (2006.01); A61K 31/519 (2006.01); A61K 31/525 (2006.01); A61K 31/555 (2006.01); A61K 31/593 (2006.01); A61K 31/714 (2006.01); A61K 31/4415 (2006.01);
U.S. Cl.
CPC ...
A61K 36/28 (2013.01); A61K 31/07 (2013.01); A61K 31/122 (2013.01); A61K 31/14 (2013.01); A61K 31/19 (2013.01); A61K 31/194 (2013.01); A61K 31/197 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/4415 (2013.01); A61K 31/455 (2013.01); A61K 31/51 (2013.01); A61K 31/519 (2013.01); A61K 31/525 (2013.01); A61K 31/555 (2013.01); A61K 31/593 (2013.01); A61K 31/714 (2013.01); A61K 33/06 (2013.01); A61K 33/18 (2013.01); A61K 39/00 (2013.01);
Abstract

The present invention provides formulations that support an individual's body during routine vaccination and adaptive immune response. The individuals who can benefit front these formulations are infants, children and adults. The formulations comprise ingredients that can be administered prior to, concurrent with or subsequent to the vaccination. The formulations of the present invention preferably act by targeting enzymatic reactions an individual's various metabolic pathways, maintaining balance between oxidative stress and methylation, maintaining balance between Th1 and Th2 responses, or a combination thereof during vaccination and adaptive immune response.

Find Patent Forward Citations

Morgan, Sarah. (2019). Formulations that provide support during vaccinations and adaptive immune system response (U.S. Patent No. 10265363). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10265363

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…